Repare Therapeutics Total Current Liabilities

Repare Therapeutics (RPTX) currently reports a total current liabilities of $12M as of September 2025. That compares with $31M in the prior-year period — down 62.6% year over year. Use the charts on this page to explore Repare Therapeutics's total current liabilities history and peer comparisons.

Repare Therapeutics's total current liabilities decreased from $31M to $12M — a 62.6% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Repare Therapeutics reported $12M in total current liabilities as of September 2025. That compares with $31M in the prior-year period — down 62.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Repare Therapeutics, and consider following RPTX for alerts when major investors trade the stock.

Repare Therapeutics is classified in the Healthcare sector. On total current liabilities, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RPTX with unrelated industries.